If you would like to submit a blog post for consideration, please email email@example.com
A question I am always asked when I teach GPs to do a skin check is “how should we examine the scalp, and how important is this for skin cancer?”. This issue is, of course, how many skin cancers “hide” under hair, how do we examine the scalp under the hair, and how important is all this? Continue reading “[2 min read] Skin cancer checks on the scalp | Prof David Wilkinson”
For a really useful, powerful and insightful overview of the situation with skin cancer in Australia, I recommend a new article published in the MJA to “celebrate” National Skin Cancer Action Week. Continue reading “[8 min read] Burden of skin cancer in Australia | Prof David Wilkinson”
In this month’s skin cancer update, the third of a four-part series, Professor Giuseppe Argenziano discusses diagnosing facial lesions, and explores the six benign features he recommends looking for – starting with pigmented and non-pigmented scales.
Professor Argenziano also refers to real-life cases he has treated, including a woman in her forties with a solitary lesion, and talks through the noticeable benign features he finds. Tune in next month for the final part of this four-part series.
Watch the full skin cancer update now:
To learn more from Professor Giuseppe Argenziano:
More skin cancer updates from Professor Giuseppe Argenziano:
- Skin Cancer Update with Prof Giuseppe Argenziano [October 2020]: Facial and non-facial lengitginous melanoma | Part 2
- Skin Cancer Update with Prof Giuseppe Argenziano [September 2020]: Facial and non-facial lentiginous melanoma
- Skin Cancer Update with Prof Giuseppe Argenziano [August 2020]: Re-excising skin lesions
It is well known that vitamin D can be effective in the prevention of skin cancer, but the synthesis of vitamin D requires ultraviolet (UV) radiation, which is a known risk factor for melanoma. A new study investigated the correlations between serum vitamin D levels and risk and prognosis of melanoma. Continue reading “[2 min read] Correlation between vitamin D and melanoma risk and prognosis”
How do you manage patients aged 85 and older with keratinocyte carcinoma? An assessment of a patient’s functional status may help to estimate which elderly patients will benefit from surgical treatment for keratinocyte carcinoma. However, predictive short-term survival in this population has not been determined. Continue reading “[2 min read] Does functional status predict survival in elderly keratinocyte carcinoma patients?”
We all use biopsy to confirm the clinical diagnosis of basal cell carcinoma (BCC), to determine the sub-type of BCC, and hence to plan the formal treatment – this is usually by excision with appropriate margins, but of course we also consider other destructive methods or topical treatments.
Colleagues will be aware of the technology that is reflectance confocal microscopy (RCM). This is special imaging of the sub-structure of the skin, typically available in specialist centres, and can be used to identify BCC sub type, and to map margins. Continue reading “[2 min read] Biopsy vs reflectance confocal microscopy in diagnosing BCC | Prof David Wilkinson”
In this month’s skin cancer update, the second of a four-part series, Professor Giuseppe Argenziano discusses what you need to know about facial lesions, and also explores the five general concepts he recommends considering when approaching these lesions; including forgetting the age of patients.
Nodular basal cell carcinoma (BCC) is most often treated with surgical excision. However, interest is increasing in minimally invasive treatments for these low-risk skin cancers. A new study reviewed the effectiveness of surgical excision compared with curettage and imiquimod cream in treating nodular BCC. Continue reading “[2 min read] Surgery vs curettage & imiquimod for nodular BCC”
In this month’s skin cancer update, Professor Giuseppe Argenziano discusses facial and non-facial lentiginous melanoma featuring real-life cases and some of his very own scholarly articles. Professor Argenziano draws on his previous research of lentiginous melanoma as a “newly defined entity”, and explores what you need to know about the special type of melanoma from a biological point of view.
New online melanoma risk calculators help predict melanoma risk and potentially deadly spread.
Clinicians and their patients now have access to a series of online calculators which will assist in prevention, early detection and optimum treatment of melanoma, ultimately saving lives. Continue reading “[1 min read] New online melanoma risk calculators”